Sivik Global Healthcare’s Bausch Health BHC Stock Holding History

Sivik Global Healthcare’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-140,000	Closed	-$3.53M	–	47
2019 Q2	$3.53M	Sell	140,000 -60,000	-30%	-$1.42M	0.85%	33
2019 Q1	$4.94M	Buy	200,000 +50,000	+33%	+$1.19M	1.82%	28
2018 Q4	$2.77M	Sell	150,000 -20,000	-12%	-$476K	1.49%	33
2018 Q3	$4.36M	Buy	170,000 +30,000	+21%	+$687K	1.56%	30
2018 Q2	$3.25M	Buy	140,000 +10,000	+8%	+$207K	1.25%	40
2018 Q1	$2.07M	Buy	130,000 +30,000	+30%	+$558K	0.97%	43
2017 Q4	$2.08M	Sell	100,000 -75,000	-43%	-$1.19M	0.77%	56
2017 Q3	$2.51M	Sell	175,000 -70,000	-29%	-$1.06M	0.85%	43
2017 Q2	$4.24M	Buy	245,000 +45,000	+23%	+$539K	1.55%	29
2017 Q1	$2.21M	Buy	+200,000	New	+$2.75M	1.03%	39

Other funds holding BHC

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Sivik Global Healthcare's BHC Position: Q3 2019 in Review

Sivik Global Healthcare sold out of Bausch Health (BHC) in Q3 2019, closing a stake of 140,000 shares — an estimated $3.53M sold.

Sivik Global Healthcare first reported a position in BHC in Q1 2017 and held it in 10 quarters. The position peaked at $4.94M in Q1 2019. 315 funds tracked by Wall St. Rank hold BHC as of Q3 2019.

Sivik Global Healthcare reported no remaining Bausch Health position as of Q3 2019 after selling out during the quarter.
Sivik Global Healthcare sold 140,000 Bausch Health shares in Q3 2019, an estimated $3.53M.
Sivik Global Healthcare first reported a position in Bausch Health in Q1 2017 and held it in 10 quarters.
Sivik Global Healthcare's Bausch Health position peaked at $4.94M in Q1 2019.
315 funds tracked by Wall St. Rank held Bausch Health as of Q3 2019.

Based on Sivik Global Healthcare's 13F filing for Q3 2019, filed 12 Nov 2019.